Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCCG Protocol for Hepatoblastoma in Children and Adolescents
NCT07300449Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2021
- Primary completion
- Dec 2027
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin, fluorouracil, vincristine, carboplatin in hepatoblastoma, sponsored by Sun Yat-sen University. Started Jun 2021; status: recruiting.
02
Drugs
cisplatindoxorubicinfluorouracilvincristinecarboplatin
03
Conditions
hepatoblastoma
Beyond the preview
Go deeper on NCT07300449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300449.